Tsuneyo Mimori Selected Research

Tsuneyo Mimori Research Topics

Disease

81	Rheumatoid Arthritis 02/2022 - 12/2002
33	Dermatomyositis (Dermatopolymyositis) 11/2022 - 09/2004
30	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2020 - 05/2005
23	Myositis (Idiopathic Inflammatory Myopathies) 07/2021 - 09/2004
20	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2003
18	Connective Tissue Diseases (Connective Tissue Disease) 10/2020 - 02/2002
17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2002
14	Arthritis (Polyarthritis) 01/2022 - 02/2004
13	Inflammation (Inflammations) 01/2022 - 12/2002
12	Neoplasms (Cancer) 11/2022 - 01/2002
12	Polymyositis 10/2019 - 09/2004
11	Immunoglobulin G4-Related Disease 05/2020 - 02/2012
8	Melanoma (Melanoma, Malignant) 01/2020 - 09/2010
8	Amyopathic dermatomyositis 09/2019 - 05/2005
6	Takayasu Arteritis (Arteritis, Takayasu's) 05/2021 - 08/2013
5	Disease Progression 11/2020 - 05/2006
5	Drug-Related Side Effects and Adverse Reactions 05/2020 - 01/2007
5	Systemic Scleroderma (Systemic Sclerosis) 05/2015 - 07/2011
5	Mixed Connective Tissue Disease (MCTD) 02/2015 - 11/2007
5	Fever (Fevers) 05/2013 - 01/2007
4	Necrosis 01/2020 - 05/2010
4	Infections 03/2019 - 07/2016
4	Collagen Diseases (Collagen Disease) 01/2013 - 10/2003
3	Muscular Diseases (Myopathy) 01/2022 - 05/2006
3	Idiopathic Interstitial Pneumonias 01/2017 - 01/2007
3	Vasculitis (Vasculitides) 06/2016 - 03/2011
3	Rheumatic Diseases (Rheumatism) 07/2015 - 01/2007
3	Antisynthetase syndrome 11/2014 - 03/2011
3	Experimental Arthritis 01/2011 - 10/2005
3	Vascular Diseases (Vascular Disease) 08/2010 - 09/2004
2	Body Weight (Weight, Body) 01/2022 - 01/2012
2	Proteinuria 12/2021 - 01/2016
2	Hypoxia (Hypoxemia) 11/2020 - 01/2017
2	Anemia 07/2020 - 01/2014
2	Hypertension (High Blood Pressure) 07/2019 - 01/2017
2	Splenomegaly 01/2019 - 02/2014

Drug/Important Bio-Agent (IBA)

52	AutoantibodiesIBA 11/2022 - 02/2002
39	AntibodiesIBA 01/2022 - 12/2003
18	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2002
14	Biological ProductsIBA 05/2020 - 04/2007
12	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2012
12	Immunoglobulin G (IgG)IBA 05/2020 - 10/2010
12	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 09/2004
11	GlucocorticoidsIBA 05/2020 - 01/2012
10	Methotrexate (Mexate)FDA LinkGeneric 05/2020 - 01/2005
10	Antirheumatic Agents (DMARD)IBA 10/2019 - 03/2009
9	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020 - 09/2004
9	AutoantigensIBA 01/2018 - 12/2002
9	EnzymesIBA 12/2016 - 09/2002
8	AntigensIBA 01/2018 - 12/2002
8	Peptides (Polypeptides)IBA 01/2018 - 05/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
7	Anti-Citrullinated Protein AntibodiesIBA 10/2020 - 11/2005
7	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 05/2005
6	Abatacept (Orencia)FDA Link 02/2022 - 07/2016
6	Ligases (Synthetase)IBA 01/2022 - 12/2003
6	CytokinesIBA 11/2020 - 01/2002
6	Rheumatoid FactorIBA 10/2020 - 12/2014
5	Ferritins (Ferritin)IBA 11/2020 - 01/2007
5	RNA (Ribonucleic Acid)IBA 05/2020 - 12/2003
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2020 - 06/2012
5	EpitopesIBA 11/2019 - 10/2010
5	Rituximab (Mabthera)FDA Link 01/2017 - 04/2007
5	Amino Acids FDA Link 08/2016 - 10/2013
5	Antinuclear AntibodiesIBA 01/2016 - 09/2004
5	Interleukin-6 (Interleukin 6)IBA 07/2014 - 02/2004
5	Interleukin-17 (Interleukin 17)IBA 07/2014 - 08/2009
5	Transfer RNA (tRNA)IBA 01/2014 - 12/2003
4	Infliximab (Remicade)FDA Link 01/2020 - 01/2011
4	iguratimodIBA 03/2019 - 05/2013
4	tocilizumab (atlizumab)FDA Link 03/2017 - 01/2009
4	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2007
4	ImmunosorbentsIBA 12/2016 - 12/2003
4	Pharmaceutical PreparationsIBA 01/2016 - 01/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2008 - 12/2003
3	Peroxidase (Myeloperoxidase)IBA 12/2021 - 10/2017
3	SteroidsIBA 05/2020 - 01/2007
3	Adalimumab (Humira)FDA Link 05/2020 - 06/2016
3	InterleukinsIBA 09/2019 - 01/2007
3	HLA-B Antigens (HLA-B)IBA 12/2018 - 08/2013
3	Complement System Proteins (Complement)IBA 09/2018 - 06/2010
3	Etanercept (Enbrel)FDA Link 03/2013 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 09/2004
3	Monoclonal AntibodiesIBA 04/2007 - 02/2004
3	FollistatinIBA 02/2004 - 12/2002
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2012
2	Signal Recognition ParticleIBA 01/2022 - 12/2016
2	cyclic citrullinated peptideIBA 10/2020 - 02/2020
2	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 10/2020 - 09/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2012
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2019 - 09/2018
2	glucose utilization inhibitor (IGU)IBA 03/2019 - 09/2017
2	Calcineurin InhibitorsIBA 01/2019 - 06/2012
2	anti-dsDNA autoantibodyIBA 01/2019 - 01/2011
2	Interleukin-2 (IL2)IBA 09/2018 - 07/2018
2	C-Reactive ProteinIBA 09/2018 - 01/2007
2	Isoleucine-tRNA LigaseIBA 05/2017 - 01/2012

Therapy/Procedure

24	Therapeutics 01/2022 - 10/2003
2	Plasma Exchange 11/2020 - 01/2017
2	Remission Induction 09/2019 - 12/2017